COO Maya Gosztyla Won the Biocom Catalyst Award
Featured article
Event
🚀 We am excited to announce that our CEO Robert Fremeau was invited to pitch at the Plug and Play Tech Center pitch event on Wednesday, August 20th, 2025, alongside alumni founders from George Washington, Ohio State, and UNC. Plug & Play's mission is to drive innovation by connecting entrepreneurs, corporations, and investors worldwide, and BrainStorm Therapeutics, Inc. is grateful for the opportunity to be part of this dynamic network.
We are pioneering an AI-powered precision medicine platform that integrates patient-derived human brain organoid disease models with advanced analytics to discover therapies that directly target the molecular drivers of synaptic dysfunction and neurodegeneration.
🔑 Why this matters:* Genetically validated, human-specific disease drivers coupled with clinically relevant biomarker-based screening endpoints and AI → higher probability of clinical success* Robust therapeutic pipeline → spanning rare neurodevelopmental disorders and major neurodegenerative diseases* Transformative impact → addressing millions of patients with debilitating brain disorders.
We are grateful to Plug and Play for this opportunity to showcase how our platform can de-risk CNS drug discovery and accelerate breakthrough therapies.
.webp)
